Shridar Ganesan

机构：Rutgers, The State University of New Jersey, NYU Langone Health, Center for Systems Biology, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, Rutgers Cancer Institute, New York University · ORCID：0000-0002-5404-3044

发表论文 458 篇 · 总被引 20937 次 · h-index 65

代表论文

• Respiration defects limit serine synthesis required for lung cancer growth and survival (2025 · Nature Communications · 被引 8)
• Multicellular immune ecotypes within solid tumors predict real-world therapeutic benefits with immune checkpoint inhibitors (2025 · Nature Communications · 被引 6)
• Abstract P2-08-25: FITWISE: Feasibility study of tirzepatide for weight loss intervention in early stage hormone receptor positive/HER2 negative breast cancer (2025 · Clinical Cancer Research · 被引 3)
• Evolution of clonal hematopoiesis during cancer treatment and its impact on outcomes (2026 · Journal of Clinical Investigation · 被引 2)
• Clonal Hematopoiesis Dynamics and Evolutionary Fitness During Cancer Treatment Impact Clinical Outcomes (2025 · medRxiv · 被引 2)
• Premature termination of early-phase cancer clinical trials: “It’s the economy, stupid!” (2026 · JNCI Journal of the National Cancer Institute · 被引 1)